Navigation Links
Sorrento(R) Cheese Launches First Omega-3 Cheese on the Market
Date:4/21/2008

r.

"The new +Plus Omega-3 snack cheese responds to consumer demand for foods that offer nutrition, health, convenience and taste all rolled into one," says Susan Thomas, Marketing Manager, Snack Cheese at Sorrento Lactalis. "We're responding to one of the top food attributes requested by consumers. With this new addition to the +Plus line, consumers can enjoy the same delicious, fresh cheese taste that Sorrento(R) is known for and feel good about eating healthy at the same time."

"A growing body of evidence links omega-3 fatty acids with a long list of health benefits," says Elizabeth M. Ward, MS, RD, author of The Pocket Idiot's Guide to the New Food Pyramids and The Complete Idiot's Guide to Feeding Your Baby and Toddler. "Don't let the word 'fat' scare you," Ward says. "It is important to avoid saturated and trans fats, but omega-3 fatty acids are beneficial, and studies shows that children and adults should be consuming more omega-3s for optimal health. "

The +Plus Omega-3 string cheese is a new option for the majority of Americans who do not eat enough omega-3 fatty acids on a regular basis. It is an especially welcome addition for those who are unable to enjoy fish.

The new +Plus Omega-3 cheese comes individually wrapped in one ounce servings, with six servings per package. The suggested retail price is $3.99 and $4.29 for Sorrento(R) and Precious(R) brand names, respectively.

In addition to the new +Plus Omega-3 product, other great snack cheeses already on the market include +Plus Calcium and Vitamin D, +Plus Lactose Free, Part Skim Mozzarella String Cheese, Reduced Fat Mozzarella String Cheese, Provolone String Cheese, Cheddar Cheese Sticks, Colby Jack Sticks and Pepper Jack Sticks. These cheeses offer kids and adults a delicious, fresh tasting snack that's great for lunchtime and on-the-go snacking.

For more information about cheese products from Sorrento Lactalis, please visit

SOURCE Sorrento Lactalis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs 2Health News:Breakfast BREAKS(R) 'Jump with Jill' Rockin' Nutrition Show Kicks off Tour in Florida Schools 2Health News:AUL Action Challenges Planned Parenthood to Reveal Financial Interest in Health Care Legislation 2Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 2Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 3Health News:New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies 4Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 2Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 3Health News:Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip 4
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 1Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 2Air Force Chief Master Sergeant Rod McKinley 28U S Air Force Retired 29 Joins MicroTech as Vice President of Strategic Partnerships 12870 3TV Ads Trigger Mindless Eating 50512 1TV Ads Trigger Mindless Eating 50512 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 1Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 2Morphotek 28R 29 Inc Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and 12866 3